Baxalta

VONVENDI

Manufacturer:

Baxalta

Vonvendi HCPCS:

J7179

HCPCS Code Descriptor:

Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco

Category:

J Code

Vonvendi NDCs:

00944-7551-02, 00944-7553-02

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00944-7551-02, 00944-7553-02

About Vonvendi:

VONVENDI is a Hematology drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J7179 is aligned to the drug VONVENDI.

ACCESS PRICING AND MORE BY REGISTERING

J7179 Added Date:

January 1, 2017

J7179 Effective Date:

January 1, 2017

J7179 Termination Date:

HCPCS Active

Vonvendi billing and coding information can be found through Baxalta at the link below:
Vonvendi patient assistance information can be found through Takeda Patient Support at the URL: https://www.hematologysupport.com/financial-assistance#about-pap
VONVENDI prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for VONVENDI. Please check back in a few weeks.